H.R. 8734 expresses the Sense of Congress regarding the safety of medication abortion. It emphasizes that federal law should take precedence over state laws that restrict the dispensing of medication abortion, aiming to ensure access to this medical option across the country.
H.R. 8734 was introduced in the 119th Congress by Patrick Ryan (Democrat) and is currently listed as “Introduced”. It is classified under the Health policy area, one of 505 bills in that area we track this Congress.
Patrick Ryan is the sponsor of 4 bills in our database this Congress, so H.R. 8734 is part of a broader legislative agenda rather than a one-off proposal.
Senate lobbying disclosures list 15 organizations lobbying on this bill’s issue area.
Our conflict-of-interest analysis rates H.R. 8734 3/10 (low risk), higher than 88% of analyzed bills; the average in Health is 3.9/10.
Supporters of H.R. 8734 have praised the bill for reinforcing the safety and accessibility of medication abortion, viewing it as a necessary measure to protect women's health rights and counteract restrictive state laws that could limit access to essential healthcare services.
Critics of H.R. 8734 argue that it undermines state authority to regulate healthcare and could lead to federal overreach. They express concerns that the bill may disregard local values and laws, potentially igniting further political and social divisions on the issue of abortion.
The analysis of H.R. 8734, which addresses the safety of medication abortion and federal preemption of state restrictions, reveals no direct industry overlaps between the sponsor Patrick Ryan's top donor industries and the bill's subject matter. While there is some lobbying activity in the policy area, the disclosed amounts do not indicate significant financial influence from the listed entities. The only disclosed contribution is from DIRSHU INTERNATIONAL, amounting to $100,000, which does not appear to have a direct connection to the abortion medication issue. Overall, the lack of direct financial ties suggests a low risk of conflict of interest for the sponsor in relation to this bill.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| DIRSHU INTERNATIONAL | MERKAVA STRATEGIES CORPORATION | $100,000 |
| CEO WORKS | SAUNDERS GLOBAL DIPLOMACY | $45,000 |
| KAZI IG | SAUNDERS GLOBAL DIPLOMACY | $15,000 |
| SOUTHERN FOLGER CONTRACTING | BBT STRATEGIES LLC | $10,000 |
| WATERFRONT GLOBAL | BBT STRATEGIES LLC | $5,200 |
| DIGITALEUROPE | VIVID STRATEGIES LLC | undisclosed |
| INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE | MERKAVA STRATEGIES CORPORATION | undisclosed |
| DR. STEPHEN SOLOWAY | MERKAVA STRATEGIES CORPORATION | undisclosed |
| ONE ISRAEL FUND | MERKAVA STRATEGIES CORPORATION | undisclosed |
| HEMOGLOBIN OXYGEN THERAPEUTICS | MERKAVA STRATEGIES CORPORATION | undisclosed |
| ATAOLLAH AMINPOUR | MERKAVA STRATEGIES CORPORATION | undisclosed |
| HERSEL NEMAN | MERKAVA STRATEGIES CORPORATION | undisclosed |
| MORAD BEN NEMAN | MERKAVA STRATEGIES CORPORATION | undisclosed |
| MARK SCOTT | MERKAVA STRATEGIES CORPORATION | undisclosed |
| BORIS MINTS | MERKAVA STRATEGIES CORPORATION | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Patrick Ryan, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
What does H.R. 8734 do?
H.R. 8734 expresses the Sense of Congress regarding the safety of medication abortion. It emphasizes that federal law should take precedence over state laws that restrict the dispensing of medication abortion, aiming to ensure access to this medical option across the country.
Has H.R. 8734 received a floor vote?
No roll-call vote on H.R. 8734 is recorded in our database yet. Its current status is “Introduced”.
Does H.R. 8734 have a conflict of interest?
Our conflict-of-interest analysis rates H.R. 8734 3/10 (low risk), higher than 88% of analyzed bills; the average in Health is 3.9/10. This score reflects overlap between the sponsor’s campaign funding, lobbying activity, and the industries the bill affects. It is a transparency indicator, not an accusation.
What is the status of H.R. 8734?
H.R. 8734 is currently “Introduced” as of our last update on May 13, 2026.
Who sponsored H.R. 8734?
H.R. 8734 was sponsored by Patrick Ryan (Democrat).
